BioSpecifics Technologies Corp.

Clinic Roundup.
BIOWORLD Today; 12/17/2009; 1196 words; ...Disease meeting in April 2010 in Vienna. o Auxilium Pharmaceuticals Inc., of Malvern, Pa., and partner BioSpecifics Technologies Corp., of Lynbrook, N.Y., reported top-line efficacy and safety results for the Phase IIb trial of Xiaflex...

BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease.
PR Newswire; 12/16/2009; 1382 words; ...PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. , a biopharmaceutical company...Thomas L. Wegman, President of BioSpecifics. "We look forward to progress...About BioSpecifics Technologies Corp. BioSpecifics Technologies...

CRWENews Highlights: OCT, OCTI, BSTC.
M2 Presswire; 12/16/2009; 1666 words; ...energy management technologies and project financing...California Lighting Technology Center and the Western...of California. BioSpecifics Technologies Corp. Announces Top...Peyronie's Disease BioSpecifics Technologies Corp...

BIOSPECIFICS TECHNOLOGIES REPORTS DISPOSITION BY PRESIDENT WEGMAN (New York)
US Fed News Service, Including US State News; 12/2/2009; 309 words; WASHINGTON, Dec. 2 -- BioSpecifics Technologies Corp. (BSTC), Lynbrook, N.Y., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...

BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference.
PR Newswire; 11/24/2009; 700 words; ...PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. , a biopharmaceutical company...products, today announced that BioSpecifics' President, Tom Wegman, will...About BioSpecifics Technologies Corp. BioSpecifics Technologies...